Materia Malta has shipped medical cannabis products to Germany, the first such shipment from the island. Materia GmbH, a subsidiary of the company, received the shipment and distributes these products to German pharmacies, according to the report.
“We are proud to be a company setting a new frontier for the Maltese and European cannabis industry,” said Nick Pateras, Managing Director of Materia in Europe.
“Our products are already helping patients in Malta to improve their quality of life, and now we can support the needs of patients in Germany as well. We believe that Malta will play an important role in the global cannabis supply chain, as it has done in the broader pharmaceutical sector for decades. We are proud to be the company setting new frontiers for the cannabis industry in Malta and Europe. »
Malta legalized medical cannabis in 2018 and the government has issued 5 production licenses so far, with more licenses expected in the coming months.
In addition, Malta Enterprises – the country’s economic development agency that helps medical cannabis companies set up shop locally – set up their business, buy equipment, transfer machinery, human resources, R&D and more. – is very aware of R&D on cannabinoid-based therapeutics and industrial processes for the extraction and cultivation of cannabis.
“We have worked tirelessly to achieve this result,” said Malta Enterprise CEO Kurt Farrugia. “From now on, we will go even further in the field of medical cannabis.”
Malta legalized cannabis for adult use last year, becoming the first country in the European Union to do so. The law allows citizens aged 18 or over to possess up to seven grams of cannabis, grow four plants at home, and keep up to 50 grams of their harvest at home.
